Fulvestrant Synthesis: The Indispensable Role of 9-Bromo-1-Nonanol as a Key Intermediate
In the realm of advanced pharmaceutical synthesis, the precision and quality of intermediate compounds are paramount to the success of the final drug product. 9-Bromo-1-Nonanol (CAS: 55362-80-6) serves as a prime example of such a critical intermediate, playing an indispensable role in the fulvestrant intermediate production. NINGBO INNO PHARMCHEM CO.,LTD. is a leading provider of this vital chemical, understanding the stringent requirements of pharmaceutical manufacturing.
Fulvestrant is a vital medication used in the treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. Its complex molecular structure requires meticulously synthesized precursors, and 9-Bromo-1-Nonanol is one such essential building block. As an organic synthesis intermediate, its chemical formula C9H19BrO and molecular weight of 223.15100 are well-defined. The presence of both a hydroxyl group and a bromine atom on a nine-carbon chain provides the necessary reactive sites for its incorporation into the Fulvestrant molecule through precise synthetic steps.
The efficacy of Fulvestrant is directly linked to the purity and consistent quality of its intermediates. Therefore, understanding the 9-bromo-1-nonanol quality standards is crucial for pharmaceutical manufacturers. High purity, typically exceeding 98.0% and often reaching 99.67% as verified by GC, along with minimal impurities such as dibromononane and controlled moisture levels (≤0.3%), are non-negotiable. These precise 9-bromo-1-nonanol chemical properties ensure predictable reaction outcomes and the safety and effectiveness of the final drug product. Businesses looking to buy 9-bromo-1-nonanol must prioritize suppliers who meet these exacting standards.
The demand for reliable 9-bromo-1-nonanol suppliers in China is high, given the country's significant contribution to the global pharmaceutical supply chain. 9-bromo-1-nonanol manufacturers in China, such as NINGBO INNO PHARMCHEM CO.,LTD., have invested heavily in research and development, state-of-the-art production facilities, and rigorous quality control systems. This allows them to consistently deliver high-quality 9-Bromo-1-Nonanol that meets international pharmaceutical standards, ensuring that critical medications like Fulvestrant can be produced efficiently and affordably.
NINGBO INNO PHARMCHEM CO.,LTD. offers extensive expertise in custom synthesis and contract manufacturing, enabling us to support pharmaceutical companies at every stage of development and production. Our capabilities range from small-scale laboratory synthesis to large-volume industrial manufacturing, all performed under strict quality management. By partnering with us, you can ensure a stable and high-quality supply of 9-Bromo-1-Nonanol, crucial for your fulvestrant intermediate production and ultimately for patient well-being.
In conclusion, 9-Bromo-1-Nonanol is far more than just a chemical intermediate; it is a critical enabler of advanced medical treatments. Its precise chemical properties and high purity are fundamental to the successful synthesis of Fulvestrant. Choosing reputable 9-bromo-1-nonanol suppliers, particularly from China, guarantees the quality and reliability necessary for pharmaceutical applications.
Perspectives & Insights
Agile Reader One
“is a leading provider of this vital chemical, understanding the stringent requirements of pharmaceutical manufacturing.”
Logic Vision Labs
“Fulvestrant is a vital medication used in the treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.”
Molecule Origin 88
“Its complex molecular structure requires meticulously synthesized precursors, and 9-Bromo-1-Nonanol is one such essential building block.”